Email: support@essaywriterpros.com
Call Us: US - +1 845 478 5244 | UK - +44 20 7193 7850 | AUS - +61 2 8005 4826

change notification for the manufacturing method

For prevention of medication accidents related to prescription drugs, Notification No. 935 of the PMSB was issued on September 19, 2000 to specify that brand name should include information of the dosage form and specification or content in addition to brand name (example, XXXX Capsules 25 mg) in principle. By Notification No. 0602009 of the PFSB dated June 2, 2004, relevant companies were requested to take active measures. The notifications issued jointly by directors of the Evaluation and Licensing Division and the Safety Division, PFSB specified handling of brand names of prescription combination drugs and heparin preparations (injection) and labeling of solutions attached to injection (Notification No. 0922002 of the Evaluation and Licensing Division, PFSB and No. 0922002 of the Safety Division, PFSB dated September 22, 2008) and handling of brand names of insulin preparations (Notification No. 0331001 of the Evaluation and Licensing Division, PFSB and No. 0331001 of the Safety Division, PFSB dated March 31, 2012).